Carcinoma in situ of lung (disorder)
CONCORDE: A Platform study of DNA damage response inhibitors in combination with conventional radiotherapy in non small cell lung cancer
Year Started: 2021
Archival tumour biopsies, Circulating Free DNA (cfDNA), Peripheral Blood Mononuclear Cell (PBMC), Toxicity Biomarkers
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- In progress
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Undifferentiated
Adult (> 40 years)
11 - 100 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
Tissue specimen | RT | Paraffin | Not applicable | 11 - 25% |